NCT01894503View on ClinicalTrials.gov

Safety and Performance of the Steroid-Releasing S8 Sinus Implant

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Chronic Sinusitis
Interventions
DRUG

S8 Sinus Implant (mometasone furoate, 1350 mcg)

Bioabsorbable sinus implant with 1350 mcg of mometasone furoate released over 90 days

Trial Locations (1)

95815

Sacramento ENT, Sacramento

Sponsors

Lead Sponsor

Intersect ENT
All Listed Sponsors
lead

Intersect ENT

INDUSTRY

NCT01894503 - Safety and Performance of the Steroid-Releasing S8 Sinus Implant | Biotech Hunter | Biotech Hunter